Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.6900
-0.0015 (-0.22%)
At close: Aug 7, 2025
R1 RCM Market Cap
Enzo Biochem has a market cap or net worth of $36.12 million as of August 8, 2025. Its market cap has decreased by -38.42% in one year.
Market Cap
36.12M
Enterprise Value
2.43M
Revenue
27.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.69
Market Cap Chart
Since June 21, 1983, Enzo Biochem's market cap has decreased from 272.34M to 36.12M, a decrease of -86.74%. That is a compound annual growth rate of -4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 36.12M | -3.20% |
| Dec 31, 2024 | 37.32M | -46.83% |
| Dec 29, 2023 | 70.18M | 0.73% |
| Dec 30, 2022 | 69.67M | -55.22% |
| Dec 31, 2021 | 155.59M | 28.91% |
| Dec 31, 2020 | 120.70M | -3.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |
| American Oncology Network | 330.70M |